Learn More
Medchemexpress LLC Cytidine 5'-(tetrahydrogen triphosphate), 2'-deoxy-2',2'-difluoro- (trisodium) | 99.2% | 569.08 | 5 MG

Supplier: Medchemexpress LLC HY17026E5MG
Gemcitabine triphosphate (dFdCTP) trisodium is the active metabolite of Gemcitabine, known for its cell-killing mechanism that involves competition with cytidine triphosphate during DNA replication, thereby inhibiting chain elongation. It partially inhibits dCMP deaminase and serves as a substrate for DNA synthesis, incorporating into cellular DNA and RNA. This leads to disruption of DNA and RNA synthesis, cell cycle arrest in G0/G1 and S phases, induction of apoptosis, and reduction of tumor cell proliferation. It is utilized in research for pancreatic cancer and non-small cell lung cancer.
- Inhibits replicative DNA polymerases α and ε
- Reduces cell viability in cancer cells
- Arrests cell cycle in S phase
- Induces caspase-3/7 activation
- Exerts antitumor effects in xenograft models
- Shows potent anti-tumor efficacy through caspase-dependent apoptosis
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.